CONSIDERATIONS ON THE PATHOGENESIS OF ACUTE MYELOID LEUKAEMIA IN A SPLENECTOMIZED HAIRY CELL LEUKAEMIA PATIENT TREATED WITH INTEFERON‐ALPHA